reviewTop 10% cited

Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long‐term follow‐up

Clinical Endocrinology · 2005 · Vol. 62(4) · pp. 397–409

Niki Karavitaki(Churchill Hospital)Claudia Brufani(Churchill Hospital)Jeremy Warner(John Radcliffe Hospital)Christopher B. T. Adams(University of Oxford)Patricia Richards(University of Oxford)Olaf Ansorge(University of Oxford)Brian Shine(Oxford Centre for Diabetes, Endocrinology and Metabolism)Helen Turner(Churchill Hospital)John Wass✉(Churchill Hospital)

View via DOI Publisher page

Abstract

Craniopharyngiomas remain tumours associated with significant morbidity. Gross total removal provides favourable results in terms of recurrences. If this cannot be achieved safely, adjuvant radiotherapy is beneficial in preventing tumour re-growth. Childhood- and adult-onset lesions generally behave similarly.

Pituitary Gland Disorders and Treatments Glioma Diagnosis and Treatment Adrenal and Paraganglionic TumorsMedicineCraniopharyngiomaRadiation therapyNatural historySurgeryPresentation (obstetrics)HydrocephalusCystPediatricsInternal medicine

MeSH terms

AdolescentAdultAgedAged, 80 and overChildChild, PreschoolCraniopharyngiomaFemaleFollow-Up StudiesHumansMaleMiddle AgedNeoplasm Recurrence, LocalPituitary NeoplasmsSurvival Rate

Citations

630

FWCI

6.85

field-weighted impact

References

Percentile

98%

vs. same field & year

Citations per year

References

Total removal of craniopharyngiomas